Trueblood Wealth Management’s Invesco S&P 500 Low Volatility ETF SPLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
15,013
+57
+0.4% +$4.2K 0.39% 81
2026
Q1
$1.09M Sell
14,956
-1,551
-9% -$115K 0.43% 74
2025
Q4
$1.18M Buy
16,507
+10
+0.1% +$719 0.46% 69
2025
Q3
$1.21M Sell
16,497
-22
-0.1% -$1.61K 0.47% 72
2025
Q2
$1.2M Sell
16,519
-243
-1% -$17.6K 0.5% 64
2025
Q1
$1.25M Sell
16,762
-2,045
-11% -$148K 0.58% 53
2024
Q4
$1.32M Hold
18,807
0.65% 43
2024
Q3
$1.35M Buy
18,807
+608
+3% +$41.8K 0.68% 38
2024
Q2
$1.18M Sell
18,199
-348
-2% -$22.5K 0.67% 40
2024
Q1
$1.22M Sell
18,547
-158
-0.8% -$10.1K 0.7% 39
2023
Q4
$1.17M Buy
+18,705
New +$1.13M 0.74% 37

Other funds holding SPLV

Trueblood Wealth Management's SPLV Position: Q2 2026 in Review

Trueblood Wealth Management increased its Invesco S&P 500 Low Volatility ETF (SPLV) stake by 0.38% in Q2 2026, buying an estimated $4.2K and bringing the position to 15,013 shares worth $1.12M. The position accounts for 0.39% of the portfolio, ranked #81.

Trueblood Wealth Management first reported a position in SPLV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.35M in Q3 2024. 755 funds tracked by Wall St. Rank hold SPLV as of Q2 2026.

  • Trueblood Wealth Management held 15,013 shares of Invesco S&P 500 Low Volatility ETF worth $1.12M as of Q2 2026.
  • Trueblood Wealth Management bought 57 Invesco S&P 500 Low Volatility ETF shares in Q2 2026, an estimated $4.2K.
  • Invesco S&P 500 Low Volatility ETF made up 0.39% of Trueblood Wealth Management's portfolio in Q2 2026, its #81 holding.
  • Trueblood Wealth Management first reported a position in Invesco S&P 500 Low Volatility ETF in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Invesco S&P 500 Low Volatility ETF position peaked at $1.35M in Q3 2024.
  • 755 funds tracked by Wall St. Rank held Invesco S&P 500 Low Volatility ETF as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.